Trading Signals: UTHR Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Fri. Dec. 22, 2023)( United Therapeutics Corp)
| UTHR latest price $143.5300 (1.07%) ($141.7700 - $145.6000) on Tue. Dec. 27, 2016. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.47% (three month average) | RSI | 59 | Latest Price | $143.5300(1.07%) | Stocks Behave Similarly | Similar Stock List | Weekly Trend | UTHR advances 3% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support UTHR advance at 0% a week (0% probability) IBB(44%) XBI(43%) XLV(42%) VT(38%) VYM(38%) | Factors Impacting UTHR price | UTHR will decline at least -1.235% in a week (0% probabilities). VIXM(-15%) TLT(-13%) UUP(-7%) SHY(-2%) IPO(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.235% (StdDev 2.47%) | Hourly BBV | 0 () | Intraday Trend | 0.4% | | | |
|
5 Day Moving Average | $142.68(0.6%) | 10 Day Moving Average | $142.16(0.96%) | 20 Day Moving Average | $136.72(4.98%) | To recent high | -1.3% | To recent low | 28.5% | Market Cap | $6.367b | | | | United Therapeutics Corp. operates as a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening diseases. It markets and sells commercial therapies to treat pulmonary arterial hypertension and high-risk neuroblastoma. The firm also involves in the research and development of new indications and delivery devices for its product, and for the organ transplantation-related technologies. The company was founded by Martine A. Rothblatt on June 26, 1996 and is headquartered in Silver Spring, MD. |